Method, device and equipment for differentiating benign and malignant breast calcification
By processing breast calcification image data using generative adversarial networks and target segmentation models, synthetic samples are generated and calcification foci regions are segmented. Deep learning and radiomics features are extracted and fused, solving the problem of accuracy and reliability in differentiating between benign and malignant breast calcifications and improving the effectiveness of early breast cancer screening.
Patent Information
- Application Number
- CN202610385082.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2026-01-07
- Filing Date
- 2026-03-26
- Publication Date
- 2026-08-04
AI Technical Summary
In current technologies, the differentiation between benign and malignant breast calcifications relies heavily on the experience of radiologists, resulting in problems such as large differences in diagnostic results, low efficiency, and a high rate of missed diagnoses of microcalcifications. Furthermore, traditional methods lack quantitative interpretation, which affects the accuracy of early breast cancer screening.
Generative adversarial networks were used to augment medical image data, generating synthetic samples that conform to pathological characteristics. Calcification lesion regions were segmented using a target segmentation model. Deep learning features and radiomics features were extracted and fused to determine the benign or malignant differentiation of breast calcifications.
It significantly improves the accuracy and interpretability of early breast cancer screening, provides reliable support for clinical diagnosis, and enhances the accuracy and reliability of differentiating between benign and malignant calcifications.